KCM
Kingdon Capital Management Portfolio holdings
AUM
$518M
This Quarter Return
+13.42%
1 Year Return
+18.14%
3 Year Return
+127%
5 Year Return
+215.17%
10 Year Return
+696.09%
AUM
$1.87B
AUM Growth
+$1.87B
(+21%)
Cap. Flow
+$255M
Cap. Flow
% of AUM
13.6%
Top 10 Holdings %
Top 10 Hldgs %
33.48%
Holding
189
New
41
Increased
46
Reduced
31
Closed
47
Top Buys
| 1 |
Visteon
VC
|
$95.5M |
| 2 |
Apple
AAPL
|
$60.2M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
$57M |
| 4 |
Tyson Foods
TSN
|
$55.6M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$50.6M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$104M |
| 2 |
WFT
Weatherford International plc
WFT
|
$54.3M |
| 3 |
Lowe's Companies
LOW
|
$38.3M |
| 4 |
Nabors Industries
NBR
|
$27.3M |
| 5 |
Cemex
CX
|
$25.5M |
Sector Composition
| 1 | Healthcare | 24.08% |
| 2 | Technology | 16.56% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Staples | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Merck
MRK
$210B
| – | – |
0
| – | – |
|
|
MTLS
177
Materialise
MTLS
$291M
| – | – |
-290,000
| Closed | -$3.24M |
|
178
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
0
| – | – |
|
|
179
Nabors Industries
NBR
$515M
| – | – |
-1,200,000
| Closed | -$27.3M |
|
180
Newell Brands
NWL
$2.64B
| – | – |
-360,000
| Closed | -$12.4M |
|
181
Perrigo
PRGO
$3.21B
| – | – |
-25,000
| Closed | -$3.76M |
|
182
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|